Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

APO-PERPHENAZINE TABLET 4 mg

Approval Number

SIN00444P

Drug Name

APO-PERPHENAZINE TABLET 4 mg

Product Name

APO-PERPHENAZINE TABLET 4 mg

Approval Date

April 27, 1988

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

N05AB03

ATC Item Name

perphenazine

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

PERPHENAZINE

Strength

4 mg

Drug MonographPerphenazine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

APO-PERPHENAZINE TABLET 4 mg - HSA Approval | MedPath